It was shown that wild-type BLCAP could inhibit the phosphorylation of signal transducer and activator of transcription 3 (STAT3) by directly interacting with it, whereas over-edited BLCAP lost its ability to inhibit STAT3 activation, which in turn promoted cancer progression [53]. The gene discussed is BLCAP; the disease is cancer.